Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.520
-0.030 (-1.94%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Erasca Employees
Erasca had 126 employees as of December 31, 2023. The number of employees decreased by 3 or -2.33% compared to the previous year.
Employees
126
Change (1Y)
-3
Growth (1Y)
-2.33%
Revenue / Employee
n/a
Profits / Employee
-$1,282,937
Market Cap
430.56M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ERAS News
- 5 days ago - Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting - GlobeNewsWire
- 10 days ago - Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results - GlobeNewsWire
- 2 months ago - Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 2 months ago - Erasca's Naporafenib Is Shaping Up Nicely For NRASm Melanoma - Seeking Alpha
- 4 months ago - Erasca Reports Third Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 5 months ago - Erasca to Present at Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - Erasca Reports Second Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 10 months ago - Erasca to Present at Upcoming Investor Conferences in June - GlobeNewsWire